✦ LIBER ✦

Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics

✍ Scribed by Shin-ya Kawashiri; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Mami Tamai; Kazuhiko Arima; Kunihiro Ichinose; Makoto Kamachi; Satoshi Yamasaki; Hideki Nakamura; Tomoki Origuchi; Hiroaki Ida; Katsumi Eguchi

Book ID: 106292219
Publisher: Springer
Year: 2009
Tongue: English
Weight: 205 KB
Volume: 20
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-009-0235-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of the anti-interleukin-6 recept

Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis

✍ Shin-ya Kawashiri; Atsushi Kawakami; Satoshi Yamasaki; Takahiro Imazato; Naoki I 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 281 KB

IL-6 receptor inhibition with tocilizuma

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

✍ Emery, P; Keystone, E; Tony, H P; Cantagrel, A; van Vollenhoven, R; Sanchez, A; 📂 Article 📅 2008 🏛 BMJ Publishing Group 🌐 English ⚖ 353 KB

Role of interleukin-6 in a patient with

Role of interleukin-6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin-6 receptor monoclonal antibody tocilizumab

✍ Prashantha M. Vaitla; Paul M. Radford; Patrick J. Tighe; Richard J. Powell; Eliz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Th17 cells are restrained by Treg cells

Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti–tumor necrosis factor antibody therapy

✍ Jenny L. McGovern; Dao X. Nguyen; Clare A. Notley; Claudia Mauri; David A. Isenb 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt

Decrease in the levels of anti-cyclic ci

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α

✍ Sachiko Onishi; Taku Yoshio; Takao Nagashima; Seiji Minota 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 167 KB